Techfields Pharmaceutical

  • Home
  • About
  • Careers
  • Pipeline
  • News
  • Contact

January 11, 2018: TECHFIELDS HAS BEGUN PHASE 3 CLINICAL TRIALS OF X0002

February 11, 2018 by Chongxi Yu Leave a Comment

Techfields has begun a Phase III clinical trial of a novel drug-X0002, TF-X0002-32(Bettermove-2), in 76 sites in the US for the treatment of the Lumbar Spine. The study title is:

A Phase 3, Multicenter, 22-Week, Double-blind and 30-Week Open Label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of Pain of Subjects with Osteoarthritis of the Lumbar Spine.

Filed Under: Uncategorized

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Contact Info

Address

1679, S. Dupont HWY, Suite 100, Dover, Delaware, 19901, USA

Telephone

001.571.276.5371

Email

chongxi@tfpharma.com or yuchongxi@hotmail.com

Website

http://www.tfpharma.com

© COPYRIGHT 2015 TFPHARMA. ALL RIGHTS RESERVED.